| Dr Hina Rahman, MB,BS | |
|
1233 34th St Nw, Bemidji, MN 56601-5112 | |
| (218) 333-5305 | |
| Not Available |
| Full Name | Dr Hina Rahman |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Location | 1233 34th St Nw, Bemidji, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114234986 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 01068339A (Indiana) | Secondary |
| 208M00000X | Hospitalist | 01068339A (Indiana) | Secondary |
| 207R00000X | Internal Medicine | 55434 (Minnesota) | Primary |
| Entity Name | Park Nicollet Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780621904 PECOS PAC ID: 7911819438 Enrollment ID: O20031104000046 |
News Archive
According to the Centers for Disease Control and Prevention (CDC), hip replacements are among the most common surgical procedures in the United States; and with osteoarthritis and obesity on the rise, demand for the procedure is expected to grow.
The federal Food and Drug Administration today approved a continuous-flow heart-assist device pioneered at the Texas Heart Institute (THI) at St. Luke's Episcopal Hospital (SLEH) for use as a permanent treatment for advanced heart failure.
Chaperone Technologies, Inc. and MerLion Pharmaceuticals Pte Ltd., both privately-held companies developing new antimicrobial drugs, announced today that they are together evaluating a unique approach for the treatment of resistant and life-threatening bacterial infections.
IN the UK alone, an estimated 7.8 million people have their lives blighted by chronic pain, and 44 per cent are failing to receive an accurate diagnosis and appropriate treatment. Now, a University of Huddersfield scientist, backed by funding from the British Pain Society and crucial support from the National Institute of Health Research, is embarking on research which aims to help doctors diagnose and treat one of the least understood but most widespread sources of chronic suffering.
› Verified 6 days ago
| Entity Name | Grand Itasca Clinic And Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669426631 PECOS PAC ID: 8123939550 Enrollment ID: O20031105000209 |
News Archive
According to the Centers for Disease Control and Prevention (CDC), hip replacements are among the most common surgical procedures in the United States; and with osteoarthritis and obesity on the rise, demand for the procedure is expected to grow.
The federal Food and Drug Administration today approved a continuous-flow heart-assist device pioneered at the Texas Heart Institute (THI) at St. Luke's Episcopal Hospital (SLEH) for use as a permanent treatment for advanced heart failure.
Chaperone Technologies, Inc. and MerLion Pharmaceuticals Pte Ltd., both privately-held companies developing new antimicrobial drugs, announced today that they are together evaluating a unique approach for the treatment of resistant and life-threatening bacterial infections.
IN the UK alone, an estimated 7.8 million people have their lives blighted by chronic pain, and 44 per cent are failing to receive an accurate diagnosis and appropriate treatment. Now, a University of Huddersfield scientist, backed by funding from the British Pain Society and crucial support from the National Institute of Health Research, is embarking on research which aims to help doctors diagnose and treat one of the least understood but most widespread sources of chronic suffering.
› Verified 6 days ago
| Entity Name | Range Regional Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669569265 PECOS PAC ID: 8022920024 Enrollment ID: O20031110000095 |
News Archive
According to the Centers for Disease Control and Prevention (CDC), hip replacements are among the most common surgical procedures in the United States; and with osteoarthritis and obesity on the rise, demand for the procedure is expected to grow.
The federal Food and Drug Administration today approved a continuous-flow heart-assist device pioneered at the Texas Heart Institute (THI) at St. Luke's Episcopal Hospital (SLEH) for use as a permanent treatment for advanced heart failure.
Chaperone Technologies, Inc. and MerLion Pharmaceuticals Pte Ltd., both privately-held companies developing new antimicrobial drugs, announced today that they are together evaluating a unique approach for the treatment of resistant and life-threatening bacterial infections.
IN the UK alone, an estimated 7.8 million people have their lives blighted by chronic pain, and 44 per cent are failing to receive an accurate diagnosis and appropriate treatment. Now, a University of Huddersfield scientist, backed by funding from the British Pain Society and crucial support from the National Institute of Health Research, is embarking on research which aims to help doctors diagnose and treat one of the least understood but most widespread sources of chronic suffering.
› Verified 6 days ago
| Entity Name | Sanford Health Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699869875 PECOS PAC ID: 6800707100 Enrollment ID: O20040715001116 |
News Archive
According to the Centers for Disease Control and Prevention (CDC), hip replacements are among the most common surgical procedures in the United States; and with osteoarthritis and obesity on the rise, demand for the procedure is expected to grow.
The federal Food and Drug Administration today approved a continuous-flow heart-assist device pioneered at the Texas Heart Institute (THI) at St. Luke's Episcopal Hospital (SLEH) for use as a permanent treatment for advanced heart failure.
Chaperone Technologies, Inc. and MerLion Pharmaceuticals Pte Ltd., both privately-held companies developing new antimicrobial drugs, announced today that they are together evaluating a unique approach for the treatment of resistant and life-threatening bacterial infections.
IN the UK alone, an estimated 7.8 million people have their lives blighted by chronic pain, and 44 per cent are failing to receive an accurate diagnosis and appropriate treatment. Now, a University of Huddersfield scientist, backed by funding from the British Pain Society and crucial support from the National Institute of Health Research, is embarking on research which aims to help doctors diagnose and treat one of the least understood but most widespread sources of chronic suffering.
› Verified 6 days ago
| Entity Name | Sanford Health Of Northern Minnesota |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770849697 PECOS PAC ID: 5597725168 Enrollment ID: O20041025000442 |
News Archive
According to the Centers for Disease Control and Prevention (CDC), hip replacements are among the most common surgical procedures in the United States; and with osteoarthritis and obesity on the rise, demand for the procedure is expected to grow.
The federal Food and Drug Administration today approved a continuous-flow heart-assist device pioneered at the Texas Heart Institute (THI) at St. Luke's Episcopal Hospital (SLEH) for use as a permanent treatment for advanced heart failure.
Chaperone Technologies, Inc. and MerLion Pharmaceuticals Pte Ltd., both privately-held companies developing new antimicrobial drugs, announced today that they are together evaluating a unique approach for the treatment of resistant and life-threatening bacterial infections.
IN the UK alone, an estimated 7.8 million people have their lives blighted by chronic pain, and 44 per cent are failing to receive an accurate diagnosis and appropriate treatment. Now, a University of Huddersfield scientist, backed by funding from the British Pain Society and crucial support from the National Institute of Health Research, is embarking on research which aims to help doctors diagnose and treat one of the least understood but most widespread sources of chronic suffering.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Hina Rahman, MB,BS 1233 34th St Nw, Bemidji, MN 56601-5112 Ph: (218) 333-5305 | Dr Hina Rahman, MB,BS 1233 34th St Nw, Bemidji, MN 56601-5112 Ph: (218) 333-5305 |
News Archive
According to the Centers for Disease Control and Prevention (CDC), hip replacements are among the most common surgical procedures in the United States; and with osteoarthritis and obesity on the rise, demand for the procedure is expected to grow.
The federal Food and Drug Administration today approved a continuous-flow heart-assist device pioneered at the Texas Heart Institute (THI) at St. Luke's Episcopal Hospital (SLEH) for use as a permanent treatment for advanced heart failure.
Chaperone Technologies, Inc. and MerLion Pharmaceuticals Pte Ltd., both privately-held companies developing new antimicrobial drugs, announced today that they are together evaluating a unique approach for the treatment of resistant and life-threatening bacterial infections.
IN the UK alone, an estimated 7.8 million people have their lives blighted by chronic pain, and 44 per cent are failing to receive an accurate diagnosis and appropriate treatment. Now, a University of Huddersfield scientist, backed by funding from the British Pain Society and crucial support from the National Institute of Health Research, is embarking on research which aims to help doctors diagnose and treat one of the least understood but most widespread sources of chronic suffering.
› Verified 6 days ago
Rodney D Will, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1233 34th St Nw, Bemidji, MN 56601 Phone: 218-333-5000 Fax: 218-759-5024 | |
Calvin Tsogmo, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1300 Anne St Nw, Bemidji, MN 56601 Phone: 218-333-5000 | |
Dr. Mary Susanna Salter, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 514 Beltrami Ave Nw, Bemidji, MN 56601 Phone: 218-766-9281 | |
Dr. John D Kolstoe, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1300 Anne St Nw, Bemidji, MN 56601 Phone: 218-333-6000 | |
Daniel Peter Dekrey, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1300 Anne St Nw, Bemidji, MN 56601 Phone: 218-333-5000 | |
Kirstin S Lesage, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1233 34th St Nw, Bemidji, MN 56601 Phone: 218-333-5522 |